Benzinga

Benzinga

Benzinga

jueves, agosto 27

Caesars Entertainment Inc

CZRNASDAQ
Trade with Public
Trade with Public
$29.66
N/A
al cierre: Aug 25, 5:00 PM EST
$29.66
N/A
Premercado: 7:19 AM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Caesars Entertainment Analyst Price Targets

Wall Street analyst price targets and consensus rating for Caesars Entertainment (CZR).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

4S.Buy
11Hold
Consensus RatingHold# Analysts15Avg. Consensus PT$36Upside to Avg. PT+22.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jul 29, 2026TD CowenLance VitanzaDowngradeBuy→Hold$31
Jul 29, 2026MacquarieChad BeynonMaintainedNeutral$31
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Downgrades Caesars Entertainment to Hold, Announces $31 Price Target

TD Cowen analyst Lance Vitanza downgrades Caesars Entertainment (NASDAQ:CZR) from Buy to Hold and announces $31 price target.
Benzinga Newsdesk

PRO
Barclays Downgrades Caesars Entertainment to Equal-Weight, Lowers Price Target to $31

Barclays analyst Brandt Montour downgrades Caesars Entertainment (NASDAQ:CZR) from Overweight to Equal-Weight and lowers the price target from $35 to $31.
Benzinga Newsdesk

PRO
Stifel Downgrades Caesars Entertainment to Hold, Maintains Price Target to $31

Stifel analyst Steven Wieczynski downgrades Caesars Entertainment (NASDAQ:CZR) from Buy to Hold and maintains the price target from $31 to $31.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Caesars Entertainment, Raises Price Target to $31

Wells Fargo analyst Trey Bowers maintains Caesars Entertainment (NASDAQ:CZR) with a Equal-Weight and raises the price target from $26 to $31.
Benzinga Newsdesk

PRO
Macquarie Downgrades Caesars Entertainment to Neutral, Lowers Price Target to $31

Macquarie analyst Chad Beynon downgrades Caesars Entertainment (NASDAQ:CZR) from Outperform to Neutral and lowers the price target from $35 to $31.
Benzinga Newsdesk

This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Residential and Caesars Entertainment.
Avi Kapoor

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved